Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willem Weimar

Showing results (71-80 of 288) with videos related to

Pageof 29
Sort By:
Therapeutic Drug Monitoring|January 1, 2015
Therapeutic Drug Monitoring of Belatacept in Kidney TransplantationGretchen N de Graav, Stein Bergan, Carla C Baan, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 15, 2011
ATP-binding cassette transporters as pharmacogenetic biomarkers for kidney transplantationNauras Shuker, Rachida Bouamar, Willem Weimar, et al.
Transplantation|December 16, 2004
Everolimus (Certican) 12-month safety and efficacy versus mycophenolate mofetil in de novo renal transplant recipientsStefan Vítko, Raimund Margreiter, Willem Weimar, et al.
Transplantation Direct|August 9, 2016
Alemtuzumab as Antirejection Therapy: T Cell Repopulation and Cytokine ResponsivenessAnne P Bouvy, Mariska Klepper, Michiel G H Betjes, et al.
Journal of Psychosomatic Research|August 27, 2013
The role of goal cognitions, illness perceptions and treatment beliefs in self-reported adherence after kidney transplantation: a cohort studyEmma K Massey, Mirjam Tielen, Mirjam Laging, et al.
Transplant Immunology|March 3, 2007
Peripheral blood manipulation significantly affects the result of dendritic cell monitoringJeroen H Gerrits, Petros Athanassopoulos, Lenard M B Vaessen, et al.
Transplantation|March 20, 2009
Successful tapering of immunosuppression to low-dose monotherapy steroids after living-related human leukocyte antigen-identical renal transplantationJacqueline van de Wetering, Jeroen H Gerrits, Nicole M van Besouw, et al.
Transplantation|January 2, 2007
A highly efficient living donor kidney exchange program for both blood type and crossmatch incompatible donor-recipient combinationsMarry de Klerk, Marian D Witvliet, Bernadette J J M Haase-Kromwijk, et al.
Health Policy (Amsterdam, Netherlands)|August 8, 2022
Induced demand in kidney replacement therapySteef Redeker, Emma K Massey, Ruben G van Merweland, et al.
Clinical Transplants|August 28, 2009
A flexible national living donor kidney exchange program taking advantage of a central histocompatibility laboratory: the Dutch modelMarry de Klerk, Marian D Witvliet, Bernadette J J M Haase-Kromwijk, et al.
Pageof 29

Showing results (71-80 of 288) with videos related to

Sort By:
Pageof 29
Therapeutic Drug Monitoring|January 1, 2015
Therapeutic Drug Monitoring of Belatacept in Kidney TransplantationGretchen N de Graav, Stein Bergan, Carla C Baan, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 15, 2011
ATP-binding cassette transporters as pharmacogenetic biomarkers for kidney transplantationNauras Shuker, Rachida Bouamar, Willem Weimar, et al.
Transplantation|December 16, 2004
Everolimus (Certican) 12-month safety and efficacy versus mycophenolate mofetil in de novo renal transplant recipientsStefan Vítko, Raimund Margreiter, Willem Weimar, et al.
Transplantation Direct|August 9, 2016
Alemtuzumab as Antirejection Therapy: T Cell Repopulation and Cytokine ResponsivenessAnne P Bouvy, Mariska Klepper, Michiel G H Betjes, et al.
Journal of Psychosomatic Research|August 27, 2013
The role of goal cognitions, illness perceptions and treatment beliefs in self-reported adherence after kidney transplantation: a cohort studyEmma K Massey, Mirjam Tielen, Mirjam Laging, et al.
Transplant Immunology|March 3, 2007
Peripheral blood manipulation significantly affects the result of dendritic cell monitoringJeroen H Gerrits, Petros Athanassopoulos, Lenard M B Vaessen, et al.
Transplantation|March 20, 2009
Successful tapering of immunosuppression to low-dose monotherapy steroids after living-related human leukocyte antigen-identical renal transplantationJacqueline van de Wetering, Jeroen H Gerrits, Nicole M van Besouw, et al.
Transplantation|January 2, 2007
A highly efficient living donor kidney exchange program for both blood type and crossmatch incompatible donor-recipient combinationsMarry de Klerk, Marian D Witvliet, Bernadette J J M Haase-Kromwijk, et al.
Health Policy (Amsterdam, Netherlands)|August 8, 2022
Induced demand in kidney replacement therapySteef Redeker, Emma K Massey, Ruben G van Merweland, et al.
Clinical Transplants|August 28, 2009
A flexible national living donor kidney exchange program taking advantage of a central histocompatibility laboratory: the Dutch modelMarry de Klerk, Marian D Witvliet, Bernadette J J M Haase-Kromwijk, et al.
Pageof 29